Does TREPROSTINIL Cause Atrial septal defect? 36 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 36 reports of Atrial septal defect have been filed in association with TREPROSTINIL (TYVASO). This represents 0.0% of all adverse event reports for TREPROSTINIL.
36
Reports of Atrial septal defect with TREPROSTINIL
0.0%
of all TREPROSTINIL reports
6
Deaths
27
Hospitalizations
How Dangerous Is Atrial septal defect From TREPROSTINIL?
Of the 36 reports, 6 (16.7%) resulted in death, 27 (75.0%) required hospitalization, and 1 (2.8%) were considered life-threatening.
Is Atrial septal defect Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 36 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Atrial septal defect?
ONDANSETRON (419)
LAMOTRIGINE (402)
VENLAFAXINE (348)
PAROXETINE (322)
SERTRALINE (304)
QUETIAPINE (275)
LEVETIRACETAM (246)
FLUOXETINE (235)
METOPROLOL (207)
CITALOPRAM HYDROBROMIDE (204)
Which TREPROSTINIL Alternatives Have Lower Atrial septal defect Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE